situation that is most frequently encountered in humans, can be obtained by burying the left ureter into the psoas muscle, but this kind of surgery leads to a poorly reproducible obstruction making it hard to obtain homogenous animal groups.
Besides these congenital or partial obstruction models, an increasingly used and popular animal model (mainly rat and mice) of obstructive nephropathy is complete unilateral ureteral obstruction (UUO) which can be performed either in newborn [12] or in adult rats and mice.
Performing UUO in newborn rat and mice allows studying the effect of obstruction on renal development since in mice and rats, in contrast to human, only 10% of nephrons are formed at birth with the remainder developing in the first postnatal week [13] . One can regret the limited number of studies using the UUO model in engineered animals in the first day of life.
The UUO maneuver leads to acute and complete obstruction of the ureter which as mentioned above is rarely found in humans but it has the advantage that it mimics, in an accelerated manner, the different stages of obstructive nephropathy leading to tubulointerstitial fibrosis: cellular infiltration, tubular proliferation and apoptosis, epithelial-mesenchymal transition (EMT), (myo)fibroblast accumulation, increased extracellular matrix (ECM) deposition and tubular atrophy ( Figure 1 ). These different features of the pathology appear rapidly, all within around one week after the induction of the pathology and are highly reproducible from one experiment to another.
UUO: the pre-genetic engineering era
Before the use of genetically modified mice to study obstructive nephropathy, the UUO model, using gene expression analysis and pharmacological tools, had already largely proven its usefulness by identifying a number of important molecules and processes involved in the pathogenesis of obstructive nephropathy [14] . For example production of angiotensin II (AII) inserm-00122385, version 1 -3 Jan 2007 was identified, acting via transcription factor nuclear factor (NF)-B, tumor necrosis factor (TNF) and transforming growth factor  (TGF), as an important cause of fibrosis.
Consequently blockage of the renin angiotensin system by angiotensin converting enzyme (ACE) inhibition is significantly reducing renal fibrosis in this obstructive nephropathy model [15] [16] [17] . However, as discussed later, recent evidence using genetically engineered mice has shown that angiotensin type 1 (AT 1 ) receptor stimulation can also be beneficial in UUO [18] .
Similarly, endogenous inhibition of extracellular matrix degrading enzyme activity was incriminated for a long time as an important cause for ECM accumulation [19] in UUO but the use of knockout mice has changed this vision [20, 21] .
UUO: insights from genetically engineered animals
In the current review we attempt to describe the contribution of genetically engineered animals (mainly gene-knockouts (see Table) but also some animals over-expressing specific proteins) to the current understanding of the development of interstitial fibrosis in obstructive nephropathy.
A major drawback in knockout mice is the apparent redundancy of biological molecules.
Possible compensation during development and during the induction of the pathology might false the interpretation of data obtained using knockout mice. Effects of knockouts that are observed in the initiation phase of the pathology but fade out when the pathology progresses are quite frequent and might be explained by adaptation. It is therefore important to confirm observations, if possible, by pharmacological knockouts. Another important issue is that one should compare the results of the knockout mice with adequate control strains (either control mice obtained by repeated (8 to 10) backcrosses to obtain the genetic background of one of the parent strains or control mice obtained by parallel breeding of both the control and the knockout strain on a mixed genetic background) since the different mouse strains are not likely to produce
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identical responses to the pathological insults. Finally, it is preferable to examine the kidney structure of genetically engineered animals before undertaking UUO. Indeed, some knockout animals including the angiotensinogen, angiotensin type 1 [22] or type 2 [8] receptor knockout mice generate animals with impaired renal development and histological lesions that look like to those obtained after an UUO.
Rather than simply reporting all published data, we have tried to describe, when possible, the more usual or non-expected results obtained using genetically modified animals. The paper is divided into the different stages of the development of obstructive nephropathy (Figure 1 ).
Furthermore there are two additional sections on two "molecules" currently identified as the main actors in the fibrotic process: the renin-angiotensin-system (RAS) and TGF. For a quick appreciation of the effect of a specific knockout on a typical parameter during the development of obstructive nephropathy, the reader is referred to the Table.
Cellular infiltration (Figure 2)
Macrophages are rare in the healthy renal cortex [23] . However, a few hours after ureteral obstruction a large number of blood-derived macrophages accumulate in the tubulointerstitial space [4] . This cellular infiltration is preceded by local expression of chemokines [24, 25] , chemokine receptors [24] and adhesion molecules [26, 27] . Despite strong correlative data, no functional studies describing the role of these molecules in UUO-induced cellular infiltration have been described. The use of knockout mice allowed to discriminate between simple fortuitous induction and genuine involvement in cellular recruitment of some of these molecules in UUO-induced nephropathy. 
Proliferation/apoptosis
Tubulointerstitial disease is associated with cell proliferation and apoptosis, however over time an imbalance between these two processes leads to unchecked apoptosis resulting in progressive However, no effect of both CKIs knockout on UUO-induced tubulointerstitial fibrosis was observed. These minor effects of both CKI might be explained by cell or renal compartment specific CKI effects (e.g. epithelial vs myofibroblasts or differential effects of UUO on renal between 50 and 70% less tubular and interstitial cell apoptosis was accompanied by a reduced interstitial volume. As was observed with knockout mice for cellular infiltration described above, the p53 knockout exhibited attenuation not elimination of apoptosis, suggesting that UUOinduced renal cell apoptosis proceeds through both p53 dependent and independent pathways.
Interstitial volume was lower in p53 deficient mice at day 7, however no difference was observed at day 15 to 30 although tubular and interstitial cell apoptosis were still different at day 15. In contrast, tubular dilatation was correlated with reduced apoptosis.
These above studies on the role of cell proliferation and apoptosis using gene knockout animals were all but conclusive about the role of these processes in the development of 
Extracellular matrix accumulation
Tubulointerstitial fibrosis is the result of an imbalance between extracellular matrix (ECM) synthesis and degradation. The pathological tubular extracellular matrix is composed of collagen I, III, and IV, V, VII, XV, laminin and fibronectin [56] . ECM degradation is thought to be largely dependent on the plasminogen system (plasminogen, plasminogen activators (PAs) and plasmin) primarily via the activation of latent metalloproteinase (MMPs). The serine protease plasmin is generated from its precursor plasminogen by two different types of PAs: urokinase type (uPA) and tissue type (tPA). Plasmin can directly degrade matrix proteins fibronectin, laminin [57] , proteoglycan [58] and type IV collagen [59] and activates pro-MMP-1 (interstitial collagenase; [60] ) and pro-MMP-3 (stromelysin-1; [61]). MMP-3 then activates MMP-9.
Independently of plasmin, uPA was shown to activate MMP-2 via membrane type 1 (MT)-MMP [62] . In theory, the combined activity of these enzymes is sufficient to degrade the extracellular matrix but knockout mice for some of the components of the ECM degrading enzyme pathways
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showed other, important, roles for these proteins in the pathology of ureteral obstruction ( Figure   4 , gray area).
Deficiency in tPA, one of the two main plasmin forming enzymes should, in theory, aggravate obstruction induced tubulointerstitial fibrosis; however, tPA deficient mice showed decreased ECM deposition in the tubulointerstitium [21] . By a yet unknown mechanism, deficiency of tPA was able to selectively block EMT via reduced expression of MMP-9 in renal interstitial fibroblasts thereby most probably reducing damage of the tubular basement membrane (Figure 3 , step 3 in the EMT process described in the preceding section) and thus inhibiting EMT. In addition, tPA deficiency did nor modify plasmin nor uPA activity in control and obstructed kidneys, suggesting absence of an effect of the knockout on the ECM degrading capability of these mice. The absence of a decreased plasmin activity in these tPA knockout mice might be explained by the fact that plasminogen is present in high concentrations in plasma (2 M) and that about 40% of this plasminogen is present in extravascular sites [63] . Therefore the plasminogen transforming activity of one PA (i.e. uPA in the tPA knockouts) might be sufficient to maintain wild type plasmin levels. Thus, in contrast to what was expected, the tPA knockouts unmasked a potential aggravating role for tPA in EMT but did not provide information about the role of this enzyme in plasmin generation for ECM degradation in the pathogenesis of tubulointerstitial fibrosis.
Another study seems to confirm the absence for a role of plasmin in ECM degradation. This time it was not the PAs that were studied but their main physiological inhibitor PAI-1 [64] . PAI-1 is up-regulated in almost all known renal diseases including UUO [65] showing a casual relationship between the pathogenesis of renal disease and this molecule. Classically it was thought that inhibition of the PA activity by PAI-1 reduced plasmin production and thus ECM degradation. Indeed, UUO in PAI-1 knockout mice showed that these mice had significantly inserm-00122385, version 1 -3 Jan 2007
lower tubulointerstitial fibrosis than their control littermates [20] . But neither the mean renal PAs nor plasmin activities were increased in PAI-1 -/-mice compared to PAI-1 +/+ mice. Surprisingly, it was the number of interstitial macrophages that was dramatically lower in PAI-1 knockout mice which was accompanied by less interstitial myofibroblasts and significant reductions in mRNA levels for TGF and procollagens I and III. This suggests that in this model PAI-1 is playing a pro-inflammatory rather than an antiproteolytic role.
The uPA receptor (uPAR) is a multifunctional protein that localizes pericellularly and binds components of the urokinase plasmin activation system including uPA and PAI-1. Binding of PAI-1 to the uPA-uPAR complex promotes internalization and degradation of both uPA and PAI-1 [64] . The uPAR receptor might play a role in the generation of active plasmin and thus in the renal fibrogenic response. uPAR knockout mice were less resistant to UUO-induced renal tubulointerstitial fibrosis than wild type mice which was accompanied by reduced renal uPA, tPA and possibly MMP9 activity [66] . Surprisingly plasmin activity was not lower in uPAR knockouts which was attributed in this paper to improper assay conditions which seems likely especially since plasmin activity was also not modified after obstruction in these experiments in contrast to earlier experiments of this laboratory [20] . An interesting observation in these experiments is decreased HGF expression in after obstruction in uPAR -/-mice compared to uPAR +/+ mice. uPA is known to activate HGF [67] . The well-known anti-fibrotic activities of HGF might also contribute, independently of an effect of the uPAR knockout on plasmin, to the observed differences.
Another control point of the ECM degrading machinery is at the level of MMP activity inhibition. This is established by tissue inhibitors of MMP (TIMPs). TIMPs, especially TIMP-1 are up-regulated during UUO-induced hydronephrosis [68, 69] . However, knockout mice for TIMP-1, the inhibitor of MMP-9, did not attenuate UUO-induced tubulointerstitial fibrosis [70] inserm-00122385, version 1 -3 Jan 2007
although MMP-9 activity was higher in kidneys of obstructed TIMP-1 knockout mice.
Compensation by other TIMPs (TIMP-2, -3) or PAI-1 or the possibility that inhibition of intrinsic MMP activity does not constitute a profibrogenic event (i.e. MMP-9 inhibition resulting in less EMT as described above) in the kidney might explain the absence of an effect of the TIMP-1 knockout.
In conclusion, studying knockout mice for the "ECM degrading enzyme system" has taught us more about less conventional roles of these proteins (inflammation, basal membrane degradation) than about their role in interstitial ECM degradation.
Renin Angiotensin System
A NF-B is also strongly involved in TNF induction during UUO [78] while TNF itself is a strong inducer of NF-B expression [80] providing an additional positive feedback loop in maintaining high NF-B activity during UUO. The interplay between AII and TNF was studied in more detail using a combination of AT 1 a and TNF receptor (TNFR1 and TNFR2) knockout mice and pharmacological tools [81] . It was shown that the double TNF receptor knockout displayed around 40% less tubulointerstitial fibrosis than the wild-type mice comparable to what was observed observed for the AT 1 a knockout mice. This level of fibrosis in double TNF receptor knockout mice was further lowered with about 25% by enalapril treatment (an ACE inhibitor) suggesting both AII dependent and independent activation of the TNF system. By studying TGF expression during UUO, these analyses combining knockouts and pharmacology also showed that levels of this cytokine are almost exclusively controlled by AII and do not involve TNF dependent pathways.
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The above studies using classical knockout mice on the RAS system confirmed the role for the AT 1 receptor as an important mediator of extracellular matrix accumulation during UUO.
However an elegant study using bone marrow transplantation from AT 1 knockout mice to wild type mice showed that AT 1 receptors can also participate in the reduction of renal fibrosis in obstructive nephropathy [18] . When the bone marrow of wild type mice was replaced by bone marrow of AT 1 receptor knockout mice, these mice developed, in contrast to what was expected, more severe interstitial fibrosis than non transplanted wild type mice. Mice transplanted with AT 1 receptor knockout bone marrow had significantly lower numbers of peripheral blood monocytes and macrophage progenitors in bone marrow with impaired phagocytic capabilities compared to wild type macrophages. It is suggested that the reduced phagocytic capabilities of the AT 1 receptor knockout bone marrow derived macrophages are at the origin of this increased interstitial fibrosis by decreased phagocytic clearance of extracellular matrix components and apoptotic cells in these mice. This combined knockout and bone marrow transplantation approach has thus allowed to dissociate between macrophage infiltration and renal fibrosis which is not possible in "simple" knockouts and presents a drawback of classical non temporal and non spatial knockouts to study complex pathological processes.
ACE inhibition has shown long before the use of genetically engineered animals to be very efficient in reducing tubulointerstitial fibrosis in experimental hydronephrosis [15] [16] [17] . Besides blocking the conversion of AI into AII, ACE inhibitors also act on the kinin-kallikrein system by inhibiting the degradation of bradykinin [82] which suggests a role for bradykinin in the reduction of UUO-induced renal fibrosis and has opened research into the role of bradykinin and related peptides in obstructive nephropathy (Figure 4 ). Bradykinin acts on a G-protein coupled receptor, the bradykinin B2 receptor. Bradykinin B2 receptor knockout mice and transgenic rats expressing increased endogenous bradykinin levels (TGR(hKLK1) rats, overexpressing the
bradykinin producing enzyme kallikrein) were used to determine the role of bradykinin and its B2 receptor in experimental hydronephrosis [83] . UUO-induced tubulointerstitial fibrosis was 2 fold higher in bradykinin B2 receptor knockout mice compared to wild type mice and significantly lower in transgenic TGR(hKLK1) than in wild type rats. This suggested that bradykinin via B2 receptor activation was antifibrotic. No effects of the knockout were observed on cell proliferation and fibroblast activation and on gene expression of a large number of genes involved in the development of tubulointerstitial fibrosis. However, the activity of proteolytic enzymes was significantly lower (tPA and MMP2 activities) in the obstructed kidneys of B2
receptor knockout compared to wild type mice. This suggested that the cascade bradykinin/B2
receptor/tPA/MMP2 was involved in the lower level of tubulointerstitial fibrosis in wild type compared to B2 receptor knockout mice although in the light recent discoveries described in the above section on extracellular matrix degradation this hypothesis might be revised soon. Finally, the bradykinin receptor knockout mice were used to determine the role of bradykinin in the beneficial effects of ACE inhibition on experimental hydronephrosis [84] . Surprisingly, although ACE-inhibition lowered significantly renal fibrosis, no difference was observed between the degree of tubulointerstitial fibrosis in ACE-inhibitor treated wild type and B2 receptor knockout mice. In contrast to the above study, it was recently shown in a model of cyclosporine-induced interstitial fibrosis that bradykinin was responsible for the anti-fibrotic effects of ACE-inhibitor benazepril which was accompanied by increased plasmin activity [85, 86] . Further studies on local renal bradykinin concentrations during UUO and other interstitial fibrosis models, which might be modified since UUO has been shown to increase ACE activity and decrease kallikrein expression [87] , or effects on the bradykinin B1 receptor are necessary to confirm the absence of a role for bradykinin in the protective effects of ACE-inhibitors in experimental hydronephrosis.

TGF related effects
As mentioned above, and long before the use of genetically engineered animals, TGF was incriminated as a key molecule in fibrosis ( Figure 6 ; [14] ). Its expression is increased in numerous fibrotic conditions [88] including experimental and human hydronephrosis [89] .
TGF1 (the main TGF isoform) knockout mice are not viable and die at mid-gestation [90] .
TGF synthesis is strongly induced by AII and the profibrotic actions of TGF are thought to involve reduction of MMP expression, increased TIMP and PAI-1 expression and increased synthesis of matrix proteins. However the mechanism by which this occurred is not clear. UUO in knockout mice of molecules interacting with TGF or involved in TGF signaling helped in better understanding of these mechanisms.
TGF activates transmembrane receptor serine/threonine kinases which transduce downstream signals to cytoplasmic latent transcription factors called Smads. Smad 2 and 3 are directly phosphorylated by one of these receptors after which they bind to Smad 4 before nuclear translocation were they act as transcriptional regulators [91] . Unlike, TGF and Smad2, Smad 3 knockout mice are viable although with a reduced life span up to 6 months due to impaired mucosal immunity [92] and has allowed to study the role of TGF signalling in experimental hydronephrosis [93] . Smad 3 knockout mice are protected against UUO-induced tubulointerstitial fibrosis which is accompanied by reduced monocyte influx, EMT and collagen deposition [93] . The results on Smad 3 null mice and complementary experiments in vitro show that it is probably the effect of Smad 3 on EMT that is the main profibrotic factor. Furthermore, Smad 3 is essential for TGF amplification since TGF levels are extremely low after UUO in TGF is maintained in a latent form and can be activated by binding to V6 integrin.
Experimental hydronephrosis in V6 integrin null mice resulted in significantly lower tubulointerstitial fibrosis [94] . This decrease in interstitial fibrosis was accompanied by lower TGF, PAI-1 and collagen I, III mRNA levels suggesting that interruption of TGF activation can protect against tubulointerstitial fibrosis. However the authors of this study also explored a possible TGF independent pathway to tubulointerstititial fibrosis by treating the V6 integrin knockout mice with AII, which increased the collagen concentration to levels comparable to obstructed wild type mice. Interestingly, AII infusion only mildly increased active TGF levels and did not change Smad 2 levels in V6 integrin knockout mice but significantly induced PAI-1 expression. These data thus suggest TGF independent profibrotic effects of AII with both pathways triggering PAI-1 expression and resulting in increased interstitial fibrosis. The AII induced TGF independent pathway for PAI-1 induction in UUO remains to be elucidated.
Other, small molecules interacting with TGF such as decorin or endoglin can modify its action and knockout out mice for both molecules have shown a role for decorin [95] but not for endoglin [96] in the development of tubulointerstitial fibrosis.
Conclusion-Perspective
Genetically modified animals have made a major contribution to our current understanding of the pathogenesis of obstructive nephropathy. These animals, when subjected to UUO, have yielded important information about the beneficial and deleterious (or, controversially, both "beneficial and deleterious") role of a specific gene product. Besides confirming the role of keymediators in obstructive nephropathy, such as TGF and AII in macrophage infiltration,
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(myo)fibroblast accumulation and ECM accumulation, the use of genetically engineered animals has also modified our vision of things that were accepted to be true in obstructive nephropathy (i.e. the beneficial and deleterious role of AII, the deleterious role of MMP9, role for PAI-1 in macrophage recruitment etc…).
The use of knockout mice has also shown the limitations of genetically modified animals.
Especially compensation during development by closely related gene-products makes interpretation of the results with knockout mice difficult. This problem might be circumvented by temporal knockouts (i.e. Cre-Lox systems) although a pharmacological knockdown is often easier to achieve. Another problem of genetically modified animals is the fact that these animals do not allow to study reversibility of the pathology. This is an important issue since renal fibrosis is often already present in an advanced state when renal disease is detected. Again temporal knockouts or pharmacological knockdown are good alternatives.
The use of genetically modified animals, mainly knockout of a single gene, has also underlined the complexity and the interconnection of the different events that lead to hydronephrosis. It shows that pharmacological treatment when aiming at one molecule at a time is probably not always the good strategy for treatment. These studies have taught us that when blocking the RAS one decreases pro-fibrotic TGF production but one probably also decreases macrophage clearance of apoptotic cells and ECM fragments beneficial in the development of hydronephrosis. Similarly, MMP9 stimulates on one hand EMT and on the other interstitial ECM degradation. These studies thus showed that future pharmacological approaches to treat hydronephrosis should consider both these deleterious and beneficial effects of one molecule on the different stages of obstructive nephropathy. 
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Angiotensinogen-KO* = - [75] Angiotensinogen-1 to 4 gene copies* = + with increasing copies [75] AT1 The remainder of the fibroblasts comes from bone marrow (14-15%) and probably local fibroblast proliferation and activation [98] . EMT involves four key events leading to epithelial cell migration and invasion into the interstitium and transition into fibroblasts 
